Kiran Khandke

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert et al. · Blood · 2003 · 354 citations · Full text

Tumor Cells Chronically Treated with a Trastuzumab–Maytansinoid Antibody–Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments

Frank Loganzo, Xingzhi Tan, Matthew Sung et al. · Molecular Cancer Therapeutics · 2015 · 254 citations

Breast Oncology, Immunology, Adc Resistance +16

Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22

John F. DiJoseph, Andrew G. Popplewell, Simon Tickle et al. · Cancer Immunology Immunotherapy · 2004 · 88 citations · Full text

B-cell Lymphoma, Lymphoid Neoplasia, Medicine +9

Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions

Marc Damelin, Alexander J. Bankovich, Albert Park et al. · Clinical Cancer Research · 2015 · 86 citations · Full text

Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells

Marc Damelin, Kenneth G. Geles, Maximillian T. Follettie et al. · Cancer Research · 2011 · 79 citations

Cancer Immunosurveillance, Tumor Heterogeneity, Tumor-initiating Cells +14